Impax Laboratories, Inc. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Impax Laboratories with three other
companies in this sector in the United States:
Horizon Pharma PLC
sales of $981.12 million
of which 100%
was Food & Drug Administration),
Prestige Brands Holdings, Incorporation
of which 82%
was North Ameriican OTC Healthcare), and
Phibro Animal Health Corp
of which 65%
was Animal Health).
Impax Laboratories reported sales of $824.43 million
December of 2016.
decrease of 4.2%
versus 2015, when the company's sales were $860.47 million.
Contributing to the drop in overall sales was the 14.7% decline
in Impax Generics, from $710.93 million to $606.32 million.
However, these declines were partially offset by the increase in sales of
Impax Specialty Pharma (up 45.9% to $218.11 million)